Get started
Author

Poul Sørensen

Observed names: P H Sorensen, Poul M. Sorensen, Poul Sorensen, Poul Sörensen
OpenAlex ID: A5023895322
Crystal structure of a soluble CD28-Fab complex
2005 · Edward J Evans, Robert M Esnouf, et al. · Nature Immunology · 181
Chemical cross‐linking with thiol‐cleavable reagents combined with differential mass spectrometric peptide mapping—A novel approach to assess intermolecular protein contacts
2000 · Keiryn L. Bennett, Martin Kussmann, et al. · Protein Science · 154
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses
2003 · José Manuel Afonso Moreira, Peter Scheipers, et al. · BMC Cancer · 143
PDF
A Theoretical Framework for Quantitative Analysis of the Molecular Basis of Costimulation
2005 · Andreas Jansson, Eleanor Barnes, et al. · The Journal of Immunology · 52
Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
2014 · N Cetinbas, M Daugaard, et al. · Oncogene · 32
Identification of Protein-Protein Interfaces Implicated in CD80-CD28 Costimulatory Signaling
2004 · Poul Sørensen, Martin Kussmann, et al. · The Journal of Immunology · 19
JNK1, but Not JNK2, Is Required in Two Mechanistically Distinct Models of Inflammatory Arthritis
2011 · Katja Denninger, Susanne Rasmussen, et al. · American Journal Of Pathology · 17
PDF
IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer
2015 · Elise K. Heon, Hasi Wulan, et al. · Biochemical and Biophysical Research Communications · 16
Translational dermatology in drug discovery: perspectives for integrating humanized xenograft models and experimental clinical studies
2007 · Thomas K. Petersen, Poul Sørensen · Drug Discovery Today · 10
Mechanisms of Protein-RNA Recognition and Assembly in Ribosomes
1984 · Roger A. Garrett, Birte Vester, et al. · University of Southern Denmark Research Portal (University of Southern Denmark) · 9
ID #536 Reshaping tumour immunity in MYC-driven medulloblastoma
2026 · Benjamin Draper, Dean Thompson, et al. · Neuro-Oncology Pediatrics
ID #1059 Antigen Prescreening Enables Phase I Clinical Trial Enrollment for GPC2-CAR T Cell Therapy in Patients with Relapsed or Refractory CNS Embryonal Tumors
2026 · Katherine Ryan, Kyle Dyson, et al. · Neuro-Oncology Pediatrics
PTHP-09. High-resolution proteomic analysis of medulloblastoma clinical samples identifies MYC immunohistochemistry as a powerful outcome predictor outperforming genetic amplification detection
2025 · Alberto Delaidelli, Fares Burwag, et al. · Neuro-Oncology
EXTH-142. Quantitative surfaceome profiling of high-risk medulloblastoma prioritizes the oncofetal antigen GPC2 for potent CAR-T cell therapy
2025 · Diren Usta, William Gwynne, et al. · Neuro-Oncology
PDF
Abstract B048: The Ewing Sarcoma Institute – a catalyst to improve outcomes for patients with Ewing sarcoma globally
2025 · Heinrich Kovar, James Amatruda, et al. · Cancer Research
59 the Bc Research Consortium of Neuro-oncology (recon)
2025 · Pariya Azarafshar, Hannah Schoenroth, et al. · Neuro-Oncology Advances
PDF
MDB-31. The eEF2 kinase supports MYC-driven medulloblastoma metabolic adaptation to nutrient deprivation
2025 · Jessica Oliveira de Santis, Alberto Delaidelli, et al. · Neuro-Oncology Pediatrics
Abstract B053: Tumor-associated macrophages diminishes IL1RAP-targeting CAR-T cell therapy efficacy in Ewing sarcoma
2024 · Yue Zhou (Joe) Huang, Melanie Rouleu, et al. · Cancer Research
Embr-20. Elongation Control of Mrna Translation Drives Group 3 Medulloblastoma
2021 · Alberto Delaidelli, Gian Luca Negri, et al. · Neuro-Oncology
Abstract B27: A link between small noncoding RNAs and mRNA translation elongation: The let7-eEF2K axis in pediatric tumor adaptation to nutrient deprivation
2020 · Alberto Delaidelli, Gian Luca Negri, et al. · Cancer Research
Works count: 20
Citation count: 633
H-index: 9
I10-index: 9
Year
Topic
Type